Normalized Income after Taxes (Annual)

Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.

NovoCure Limited (NVCR) had Normalized Income after Taxes of $-207.04M for the most recently reported fiscal year, ending 2023-12-31.

Quarterly Annual

Figures for fiscal year ending 2023-12-31

Income Statement Financials
Revenue	$509.34M
Net Income	$-207.04M
Cost of Goods Sold	$128.28M
Gross Profit	$381.06M
Operating Expenses	$742.21M
Operating Income	$-232.87M
Non-Operating Income/Expense	$41.13M
Pre-Tax Income	$-191.74M
Normalized Pre-Tax Income	$-191.74M
Income after Taxes	$-207.04M
Income from Continuous Operations	$-207.04M
Consolidated Net Income/Loss	$-207.04M
Normalized Income after Taxes	$-207.04M
EBIT	$-232.87M
EBITDA	$-244.99M
Weighted-Average Shares Outstanding (Basic)	106.39M
Weighted-Average Shares Outstanding (Diluted)	106.39M
Earnings per Share (EPS) (Basic)	$-1.95
Earnings per Share (EPS) (Diluted)	$-1.95
Balance Sheet Financials
Current Assets	$1.03B
Property, Plant, and Equipment	$62.86M
Long-Term Assets	$111.72M
Total Assets	$1.15B
Current Liabilities	$179.12M
Long-Term Debt	$568.82M
Long-Term Liabilities	$604.52M
Total Liabilities	$783.63M
Common Equity	$362.50M
Tangible Shareholders Equity	$362.50M
Shareholders Equity	$362.50M
Common Shares Outstanding	107.08M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-73.34M
Cash Flow from Investing Activities	$184.15M
Cash Flow from Financial Activities	$15.79M
Beginning Cash	$115.83M
End Cash	$242.56M
Increase/Decrease in Cash	$126.73M
Stock-Based Compensation	$115.61M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	5.78
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.61
Debt to Equity Ratio	1.57
Gross Margin	74.81%
Operating Margin	-45.72%
EBIT Margin	-45.72%
EBITDA Margin	-48.10%
Pre-Tax Profit Margin	-37.64%
Profit Margin	-40.65%
Free Cash Flow	$-100.43M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.44
Inventory Turnover	3.36
Receiveable Turnover	6.07
Days Sales in Receivables	60.12
Return on Equity	-57.12%
Return on Tangible Equity	-57.12%
Return on Assets	-18.06%
Return on Investments	-22.23%
Book Value Per Share	$3.39
Free Cash Flow per Share	$-0.94
Operating Cash Flow per Share	$-0.69

Data from Zacks Investment Research, Inc.